EcoDrugPlus

Trace Amine Associated Receptor 1

Ensembl ID : ENSSDUG00000008461
Gene Symbol: TAAR1
1 Cross references
335 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSSDUG00000008459
Gene Symbol: TAAR1
1 Cross references
330 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSSDUG00000008438
Gene Symbol: TAAR1
3 Cross references
348 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSSDUG00000008432
Gene Symbol: TAAR1
3 Cross references
347 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSSDUG00000012764
Gene Symbol: TRPA1
3 Cross references
200 Possible Orthologues:

Transmembrane O-Methyltransferase-Like

Ensembl ID : ENSSDUG00000007959
Gene Symbol: LOC111232730
2 Cross references
177 Possible Orthologues:

Transthyretin

Ensembl ID : ENSSDUG00000018623
Gene Symbol: TTR
3 Cross references
178 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSSDUG00000019972
Gene Symbol: TPH1
3 Cross references
207 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSSDUG00000012063
Gene Symbol: TUBA4A
3 Cross references
170 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSSDUG00000014773
Gene Symbol: LOC111218500
3 Cross references
156 Possible Orthologues:

Tubulin Alpha-1b Chain

Ensembl ID : ENSSDUG00000003775
Gene Symbol: LOC111234898
2 Cross references
189 Possible Orthologues:

Tubulin Beta Chain

Ensembl ID : ENSSDUG00000013974
Gene Symbol: LOC111230072
2 Cross references
170 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).